Micah Paul Young

Array ( [id] => 20749169 [patent_doc_number] => 20260151387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-04 [patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS [patent_app_type] => utility [patent_app_number] => 19/464192 [patent_app_country] => US [patent_app_date] => 2026-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19464192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20650352 [patent_doc_number] => 20260102363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-16 [patent_title] => TREATMENT METHOD AND ANTIFUNGAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/418539 [patent_app_country] => US [patent_app_date] => 2025-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19418539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20761148 [patent_doc_number] => 20260158120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-11 [patent_title] => FUNGAL-DERIVED ENZYME COMPOSITION AND METHOD FOR TREATING EXOCRINE PANCREATIC INSUFFICIENCY [patent_app_type] => utility [patent_app_number] => 19/411641 [patent_app_country] => US [patent_app_date] => 2025-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19411641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20613589 [patent_doc_number] => 20260083674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-26 [patent_title] => OXAZOLIDINONE LIPOSOME COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 19/405695 [patent_app_country] => US [patent_app_date] => 2025-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19405695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20706705 [patent_doc_number] => 20260131033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-14 [patent_title] => RADIOLABELED FRUCTOSE DERIVATIVES FOR MEDICAL IMAGING [patent_app_type] => utility [patent_app_number] => 19/329432 [patent_app_country] => US [patent_app_date] => 2025-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20192181 [patent_doc_number] => 20250268891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS [patent_app_type] => utility [patent_app_number] => 19/207162 [patent_app_country] => US [patent_app_date] => 2025-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19207162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20391650 [patent_doc_number] => 20250367125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => ORAL POLYPEPTIDE COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/194059 [patent_app_country] => US [patent_app_date] => 2025-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19194059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20293789 [patent_doc_number] => 20250319032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => PHARMACEUTICAL COMPOSITIONS OF RIBOCICLIB [patent_app_type] => utility [patent_app_number] => 19/176436 [patent_app_country] => US [patent_app_date] => 2025-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83204 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19176436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20163790 [patent_doc_number] => 20250255836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD [patent_app_type] => utility [patent_app_number] => 19/176038 [patent_app_country] => US [patent_app_date] => 2025-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29204 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19176038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20534435 [patent_doc_number] => 12551486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Rivaroxaban formulation [patent_app_type] => utility [patent_app_number] => 19/092739 [patent_app_country] => US [patent_app_date] => 2025-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19092739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20793805 [patent_doc_number] => 20260174699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-25 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING UNIFORM BLENDS OF REBOXETINE [patent_app_type] => utility [patent_app_number] => 19/079284 [patent_app_country] => US [patent_app_date] => 2025-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19079284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20356195 [patent_doc_number] => 12472174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Bupropion dosage forms with reduced food and alcohol dosing effects [patent_app_type] => utility [patent_app_number] => 19/063023 [patent_app_country] => US [patent_app_date] => 2025-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2746 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19063023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20293856 [patent_doc_number] => 20250319099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => METHOD OF ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL WITH A DUAL CHAMBER SYRINGE [patent_app_type] => utility [patent_app_number] => 19/059823 [patent_app_country] => US [patent_app_date] => 2025-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19059823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20293778 [patent_doc_number] => 20250319021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => COMPOSITION OF HYDROGEL LOADED WITH HORMONE [patent_app_type] => utility [patent_app_number] => 19/059216 [patent_app_country] => US [patent_app_date] => 2025-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14181 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19059216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20293777 [patent_doc_number] => 20250319020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => DUAL CHAMBER SYRINGE FOR ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL [patent_app_type] => utility [patent_app_number] => 19/059162 [patent_app_country] => US [patent_app_date] => 2025-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13934 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19059162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20371208 [patent_doc_number] => 12478622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Bupropion dosage forms with reduced food and alcohol dosing effects [patent_app_type] => utility [patent_app_number] => 19/045249 [patent_app_country] => US [patent_app_date] => 2025-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1058 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19045249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19814989 [patent_doc_number] => 20250073196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE RELEASING PROSTAMIDE [patent_app_type] => utility [patent_app_number] => 18/949815 [patent_app_country] => US [patent_app_date] => 2024-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19752648 [patent_doc_number] => 20250041213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => STABLE SOLID FINGOLIMOD DOSAGE FORM [patent_app_type] => utility [patent_app_number] => 18/919763 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19930411 [patent_doc_number] => 12303604 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-20 [patent_title] => Pharmaceutical formulations comprising naltrexone and/or bupropion [patent_app_type] => utility [patent_app_number] => 18/917080 [patent_app_country] => US [patent_app_date] => 2024-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5566 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18917080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19875746 [patent_doc_number] => 20250108003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => METHODS OF TREATING ALLERGIC CONJUNCTIVITIS [patent_app_type] => utility [patent_app_number] => 18/915988 [patent_app_country] => US [patent_app_date] => 2024-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915988 [rel_patent_id] =>[rel_patent_doc_number] =>)